S. 3216 · 116th Congress
Access to Breast Cancer Diagnosis Act of 2020
- Stage
- In committee
- Sponsor
- Roy Blunt
- Introduced
- 2020-01-16
- Latest action
- 2020-01-16 · Introduced in Senate
Summary
Access to Breast Cancer Diagnosis Act of 2020
This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).